Global Companion Diagnostics Market, By Application(Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma), Technology(Immunohistochemistry, Real-time PCR, Gene Sequencing, FISH), and Geography - Trends, Analysis and Forecast till 2026
- Report code : CMI2109 |
- Industry :
Clinical Diagnostic
- Published On : Feb 2017 |
- Pages : 195 Pages |
- Format :
Companion Diagnostics – Growth Companion for Personalized Medicine
Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy. Companion diagnostic is one such emerging field for target biomarker identification reducing clinical trial cost and time to market the product.
Pharmaceutical companies need to constantly innovate and integrate latest technological breakthroughs in order to sustain in the companion diagnostics market, given the looming threat of new technologies posing threat to existing product portfolio and research pipeline. Novartis AG focuses on R&D for biomarkers with the help of its partner SomaLogic, Inc., once they begin the process of finalizing the drug candidate. Such pre-work is now part of the routine of drug development, something that was an alien practice till around a decade ago. The U.S. FDA released a draft guideline for companion diagnostics in July 2016, providing a structure for the pharmaceutical companies to co-develop CDx test along with the drug therapies.
The global companion diagnostics market was valued at US$ 1,614.5 million in 2015 and is expected to witness a robust CAGR of 12.0% during the forecast period (2016 – 2024).
Figure 1. Global Companion Diagnostics Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2014–2024
Source: Coherent Market Insights Analysis (2017)
To have a snippet of the report, request Report Sample
Low cost and clinical benefits of companion diagnostics is expected to drive growth of the market
The ecosystem of pharmaceuticals industry is one of the major factors driving growth of the companion diagnostics market. The providers of healthcare products and services, and patients who utilize these products and services is expected to be benefitted by a collaborative approach. The innovation of CDx helped drug developers in reducing the development costs, developing highly effective therapeutic products, and improving the time to market by identifying the effectiveness of a drug against particular biomarkers. Moreover, better treatment outcomes and lower morbidity risk are benefits offered to the patients. Also, accurate diagnosis and determination of targeted cancer therapy has become much easier due to advanced technologies such as PCR, immunohistochemistry, and gene sequencing.
Advancements in technology and increasing research on CDx has resulted in increasing approval of drug therapies with diagnostic tests alongside it. As per the Regulatory Affirms Professionals Society (RAPS), the share of drugs and biologics approved alongside a diagnostic test, by the U.S. FDA, increased from 20% in 2014 to 28% in 2015.
Research collaborations to improve the time to market the product
An integrated and more evidence-based approach is driving partnerships in the global companion diagnostics market. According to Wildwood Ventures Ltd., the number of global deal in companion diagnostics market has increased from 13 in 2007 to 66 in 2013. Since, developing CDx test along with drug therapy is a capital intensive and complex process, industry players are collaborating to leverage on each other’s expertise. For instance:
- Invivoscribe Technologies Inc., collaborated with Novartis AG and Astellas Pharma Inc. to develop companion diagnostics for their drugs under pipeline.
- Invivoscribe also announced a long-term partnership with Thermo Fisher Scientific in January 2017, develop and commercialize IVD assays for Applied Biosystems® 3500 Dx Series Genetic Analyzers. Invivoscribe Technologies Inc. is a global company engaged in providing clonality and biomarker test solutions for oncology and personalized molecular diagnostics.
- AstraZeneca plc entered into a deal with Abbott Laboratories, Inc. in 2015, to develop a companion diagnostic test for tralokinumab, used for treating severe asthma.
- Singulex, Inc. entered into a strategic collaboration with QIAGEN N.V. in January 2017 to develop companion diagnostics using Singulex's proprietary Single Molecule Counting (SMC) immunodiagnostic platform
Increasing number of research collaborations is expected to improve the time to market of highly effective targeted drug therapies. This would in-turn augment the growth of companion diagnostics market.
Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying genetic mutations and the health and treatment approach implications. In July 2016, the U.S. FDA released a draft guideline for development of a therapeutic product accompanying an IVD companion diagnostic. Companion diagnostics include Gleevec (imatinib mesylate) and BCR-ABL LDT and DAKO C-KIT PharmDx, Herceptin (trastuzumab) and DAKO Herceptest; and Nolvaldex (tamoxifen) and laboratory-developed estrogen receptor positive test.
Market Dynamics
Companion diagnostics are beneficial for pharmaceutical companies who face challenges with respect to high drug development cost, safety and outcome of clinical trials, and long product approval time. Companion diagnostics lowers development costs, improves time to market and enhances drug safety by enabling rapid identification of target biomarker and the most effective drug therapy. For patients, the technology provides better treatment outcomes and lower morbidity risk. Use of technologies such as PCR, immunohistochemistry, and gene sequencing has enabled accurate diagnosis and determination of targeted cancer therapy. As the CDx tests also aid in revealing the off-target effects of a drug along with identification of a molecular target, CDx have become and indispensable tool for oncologists.
Market Taxonomy
This report segments the global companion diagnostics market on the basis of application, technology, and geography. On the basis of application, the market is categorized into breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma, and others. On the basis of technology, the market is segmented into immunohistochemistry, real-time PCR, gene sequencing, Fluorescence in situ hybridization (FISH), and others. For comprehensive understanding of market dynamics, the global companion diagnostics market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
- This report provides in-depth analysis of the companion diagnostics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global companion diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
- Key companies covered as a part of this study include Abbott Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation, GE Healthcare, Qiagen N.V., Roche Diagnostics, Myriad Genetics, Inc., bioMérieux SA, Illumina, Inc. and Siemens Healthcare
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, technology upgrades, market expansion, and marketing tactics
- The global companion diagnostics market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for companion diagnostics, research and consulting firms, new entrants, and financial analysts
- Various strategy matrices used in analyzing the companion diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
- Global Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Global Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real-time PCR
- Gene Sequencing
- FISH
- Others
- Global Companion Diagnostics Market, By Geography:
- North America
- U.S.
- U.S. Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- U.S. Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Canada
- Canada Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Canada Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Europe
- U.K.
- U.K. Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- U.K. Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Germany
- Germany Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Germany Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Italy
- Italy Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Italy Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- France
- France Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- France Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Spain
- Spain Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Spain Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Russia
- Russia Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Russia Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Rest of Europe
- Rest of Europe Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Rest of Europe Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Asia-Pacific
- China
- China Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- China Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- India
- India Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- India Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Japan
- Japan Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Japan Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- ASEAN
- ASEAN Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- ASEAN Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Australia
- Australia Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Australia Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Australia Companion Diagnostics Market, By Application:
- South Korea
- South Korea Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- South Korea Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- South Korea Companion Diagnostics Market, By Application:
- Rest of Asia Pacific (APAC)
- Rest of Asia Pacific Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Rest of Asia Pacific Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Rest of Asia Pacific Companion Diagnostics Market, By Application:
- Latin America
- Brazil
- Brazil Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Brazil Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Brazil Companion Diagnostics Market, By Application:
- Mexico
- Mexico Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Mexico. Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Mexico Companion Diagnostics Market, By Application:
- Rest of Latin America
- Rest of Latin America Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Rest of Latin America Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Rest of Latin America Companion Diagnostics Market, By Application:
- Brazil
- Middle East
- GCC
- GCC Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- GCC Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- GCC Companion Diagnostics Market, By Application:
- Israel
- Israel Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Israel Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Israel Companion Diagnostics Market, By Application:
- Rest of Middle East
- Rest of Middle East Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Rest of Middle East Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Rest of Middle East Companion Diagnostics Market, By Application:
- GCC
- Africa
- North Africa
- North Africa Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- North Africa Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- North Africa Companion Diagnostics Market, By Application:
- Central Africa
- Central Africa Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Central Africa Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- Central Africa Companion Diagnostics Market, By Application:
- South Africa
- South Africa Companion Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- South Africa Companion Diagnostics Market, By Technology:
- Immunohistochemistry
- Real Time PCR
- Gene Sequencing
- FISH
- Others
- South Africa Companion Diagnostics Market, By Application:
- North Africa
- Company Profiles
- Abbott Laboratories, Inc. *
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- Agilent Technologies, Inc.
- Danaher Corporation
- GE Healthcare
- Qiagen N.V.
- Roche Diagnostics
- Myriad Genetics, Inc.
- bioMérieux SA
- Siemens Healthcare
- Illumina, Inc.
- Abbott Laboratories, Inc. *
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Application
- Market Snippet By Technology
- Market Snippet By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Supply Side Drivers
- Demand Side Drivers
- Economic Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Epidemiology/Prevalence/Incidence
- Merger and Acquisitions
- New Product Approvals/Launch
- Promotion and Marketing Initiatives
- Cost Tier Down Analysis
- Global Biopharmaceuticals and Biomedicine Market, By Application, 2014 - 2024 (US$ Million)
- Introduction
- Market Share Analysis, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, 2014 - 2024
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- Gastric Cancer
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- Global Biopharmaceuticals and Biomedicine Market, By Technology, 2014 - 2024 (US$ Million)
- Introduction
- Market Share Analysis, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, 2014 - 2024
- Segment Trends
- Real-Time PCR
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- Gene Sequencing
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- FISH
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
- Global Biopharmaceuticals and Biomedicine Market, By Regions, 2014 - 2024 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, For Regions, 2014 - 2024
- North America
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- U.S.
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Canada
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Europe
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- U.K.
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Germany
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Italy
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- France
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Russia
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Rest of Europe
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Asia Pacific
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- China
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- India
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Japan
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- ASEAN
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Australia
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- South Korea
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Rest of Asia Pacific
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Latin America
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- Brazil
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Mexico
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Rest of Latin America
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Middle East
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- GCC Countries
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Israel
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Rest of Middle East
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Africa
- Market Share Analysis, By Country, 2015 and 2024 (%)
- Y-O-Y Growth Analysis, By Country, 2014 - 2024
- Northern Africa
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Central Africa
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- South Africa
- Country Trends
- Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
- Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Abbott Laboratories, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Danaher Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Qiagen N.V.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Roche Diagnostics
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- bioMérieux SA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Myriad Genetics, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Siemens Healthcare
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Illumina, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 90 market data tables and 40 figures on "Companion Diagnostics Market - Global forecast to 2024”.
Research Methodology
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
- Primary Research (Trade Surveys and Experts Interviews)
- Desk Research
- Proprietor Data Analytics Model
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
- National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
- Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
- Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
- Trade association, National and international media and trade press.
- Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
- Scientific journals, and other technical magazines and whitepapers.
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Data Standardization:
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
- Micro-economic indicators
- Macro-economic indicators
- Environmental indicators
- Socio-political indicators
- Technology indicators
Data Processing
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
Data Validation
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
- It provides first-hand information on the market dynamics, outlook, and growth parameters.
- Industry experts validates the estimates which helps the company to cement the on-going research study.
- Primary research includes online surveys, face-to face interviews, and telephonic interviews.
The primary research is conducted with the ecosystem players including, but not limited to:
- Raw Material Suppliers
- Manufacturers
- System Integrators
- Distributors
- End-users
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.